dc.contributor.author | Irawan, Eka Deddy | |
dc.contributor.author | Munawaroh, Siti | |
dc.contributor.author | Sari, Lusia Oktora Ruma Kumala | |
dc.date.accessioned | 2016-05-11T06:58:53Z | |
dc.date.available | 2016-05-11T06:58:53Z | |
dc.date.issued | 2016-05-11 | |
dc.identifier.issn | 1693-6485 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/73885 | |
dc.description.abstract | The purpose of this study is to provide controlled release dosage by avoiding first pass metabolism and
enzymatic degradation. Propranolol hydrochloride mucoadhesive buccal tablets was prepared by direct
compression method using carbopol and CMC Na as buccal mucoadhesive polymer. Buccal mucoadhesive
strength measured using buccal mucosa of gout. Testing the release of propranolol hydrochloride was determined
by dissolution test using phosphate buffer solution pH 6,8 for 8 hours. Dissolution efficiency (DE) was calculated to
describe the overall release profiles and used in determining the optimum response. The optimum region is
determined using factorial design with the design criteria of response force for 20-40 grams of mucoadhesive buccal
and DE
480
between 45-55%. The amount of carbopol that can provide the optimum response is between the range
of 53,27-55 mg while the amount of CMC Na can provide the optimum response range is between 70-100 mg. | en_US |
dc.language.iso | id | en_US |
dc.subject | buccal mucoadhesive | en_US |
dc.subject | propranolol hydrochloride | en_US |
dc.subject | Carbopol | en_US |
dc.subject | CMC Na | en_US |
dc.title | OPTIMASI KOMPOSISI KARBOPOL DAN NATRIUM KARBOKSIMETILSELULOSA SEBAGAI SISTEM BUCCAL MUCOADHESIVE TABLET PROPRANOLOL HIDROKLORIDA | en_US |
dc.type | Article | en_US |